Clinical and hemodynamic improvements after adding ambrisentan to background PDE5i therapy in patients with pulmonary arterial hypertension exhibiting a suboptimal therapeutic response (ATHENA-1)
収録刊行物
-
- Respiratory Medicine
-
Respiratory Medicine 126 84-92, 2017-05
Elsevier BV